Spectral Medical Inc (TSE:EDT) insider Debra-Anne Foster bought 100,000 shares of the stock in a transaction on Tuesday, February 11th. The shares were acquired at an average cost of C$0.38 per share, for a total transaction of C$37,500.00. Following the purchase, the insider now owns 234,855 shares in the company, valued at C$88,070.63.
Shares of EDT opened at C$0.75 on Friday. Spectral Medical Inc has a 52-week low of C$0.30 and a 52-week high of C$0.85. The company has a quick ratio of 3.64, a current ratio of 4.24 and a debt-to-equity ratio of 21.26. The firm’s fifty day moving average is C$0.75 and its two-hundred day moving average is C$0.55. The stock has a market cap of $155.81 million and a PE ratio of -57.69.
Spectral Medical (TSE:EDT) last announced its quarterly earnings results on Thursday, November 14th. The company reported C($0.01) earnings per share for the quarter. The firm had revenue of C$0.53 million for the quarter. As a group, research analysts anticipate that Spectral Medical Inc will post -0.06 earnings per share for the current year.
Spectral Medical Company Profile
Spectral Medical Inc focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan.
Featured Story: FTSE 100 Index
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.